Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma - Madle, Michael; Krämer, Isabelle; Giesen, Nicola; Schwarzbich, Mark-Alexander; Wuchter, Patrick; Egerer, Gerlinde; Ho, Anthony Dick; Witzens-Harig, Mathias (Blood, 2014)
Gesehen am 02.07.2015